Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
179.34B | 187.21B | 188.59B | 172.07B | 152.20B | 186.76B | Gross Profit |
99.94B | 104.08B | 95.38B | 86.58B | 84.41B | 101.80B | EBIT |
382.00M | -9.50B | 4.10B | 494.00M | 2.71B | 8.12B | EBITDA |
21.52B | 3.90B | 16.25B | 11.18B | 8.83B | 14.15B | Net Income Common Stockholders |
4.36B | -8.63B | -1.77B | 1.73B | 7.03B | 3.47B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
32.15B | 35.54B | 26.78B | 37.48B | 65.25B | 29.36B | Total Assets |
286.74B | 294.03B | 285.30B | 299.18B | 322.76B | 277.69B | Total Debt |
27.29B | 20.64B | 20.41B | 25.30B | 55.10B | 17.07B | Net Debt |
-2.05B | -12.90B | -6.36B | -11.91B | -8.46B | -10.84B | Total Liabilities |
79.38B | 78.89B | 72.18B | 78.31B | 102.51B | 65.45B | Stockholders Equity |
204.11B | 211.83B | 209.83B | 217.99B | 217.25B | 208.16B |
Cash Flow | Free Cash Flow | ||||
6.35B | 7.91B | 2.29B | 6.83B | -1.34B | 6.34B | Operating Cash Flow |
8.59B | 11.29B | 7.33B | 16.62B | 4.26B | 13.32B | Investing Cash Flow |
8.72B | 14.05B | 4.30B | -2.93B | -3.92B | 2.69B | Financing Cash Flow |
-19.12B | -20.21B | -22.94B | -41.12B | 34.97B | -17.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $2.11B | 10.59 | 44.55% | 3.38% | -1.08% | -8.20% | |
72 Outperform | $1.38B | 27.53 | 11.97% | ― | 9.09% | 106.50% | |
67 Neutral | $1.82B | 11.62 | 31.30% | ― | 0.76% | 49.95% | |
64 Neutral | $1.81B | 40.96 | 3.45% | 1.49% | -10.68% | ― | |
62 Neutral | $6.84B | 11.22 | 2.83% | 3.93% | 2.65% | -21.93% | |
57 Neutral | $2.87B | ― | 58.47% | ― | -6.35% | 79.04% | |
52 Neutral | $1.73B | ― | -23.24% | ― | -33.72% | -892.32% |